Common Contracts
1 similar Master Clinical Trial Agreement contracts
Active Master Clinical Trial Agreements 11/29/2017Master Clinical Trial Agreement • November 29th, 2017
Sponsor Amendments Effective Date Termination Date Abbott Vascular Inc. 1 and 2 3/17/2011, last amended 8/6/2013 None Abiomed, Inc. 1/30/2008 None Amgen, Inc. 8/18/2005 None Astellas Pharma Global Development, Inc. 10/2/2014 10/1/2019 AstraZeneca LP (Confidentiality Agreement) 1/22/2015 1/21/2020 Bayer Healthcare Pharmaceuticals, Inc 10/14/2014 10/13/2019 Beckman Coulter, Inc. 2/16/2011 2/15/2016 Biogen Idec, Inc 2/13/2014 2/12/2019 Boehringer Ingelheim Pharmaceuticals, Inc. (MCDA) 12/19/2016 12/18/2026 Boehringer Ingelheim Pharmaceuticals, Inc. (MCTA) 1/3/2017 1/2/2022 Celgene Corporation 1 5/2/2011 5/2/2021 Eli Lilly and Company: Lilly Research Laboratories 3/11/2005 None Genentech, Inc. 5/31/2017 5/30/2027 Gilead Sciences, Inc. 1 and 2 11/21/2007, last amended 8/12/2013 11/20/2019 Johnson & Johnson Vision Care, Inc. 1 10/10/2011 10/11/2019 Merck & Co., Inc. 5/15/2014 None Novartis Pharmaceuticals Corporation 1, 2, 3, 4. and 5 9/7/2005, last amended 9/1/2015 8
